Building a Diversified Healthcare Platform as Exosome Science, Telehealth, Diagnostics & Strategic Acquisitions Converge: NexTel Medical (OTCID: MAJI)

Sep 16, 2026

With a potential Q4 commercial launch, expanding diagnostic opportunities, a major telehealth platform, veterinary oncology initiatives and a proposed Xycota acquisition, NexTel is positioning $MAJI around multiple potential growth catalysts

SAINT PETERSBURG, Fla. - Sept. 16, 2026 - PRLog -- NexTel Medical Corp. (Stock Symbol: MAJI) is rapidly evolving into a much broader healthcare and biotechnology story than the company investors may have been following earlier this year. Formerly known as Exousia Pro, NexTel has spent 2026 assembling what management describes as an integrated healthcare ecosystem combining proprietary exosome technology, diagnostics, telehealth, pharmaceutical access, wellness products and strategic distribution infrastructure.

The company's most recent developments suggest that the investment story is increasingly centered on commercialization and platform expansion, rather than relying on a single biotechnology program.

Perhaps most importantly, NexTel now has several potential catalysts developing simultaneously.

A Rapidly Expanding NexTel Healthcare Ecosystem

At the heart of the strategy is NexTel's proprietary Maxasome™ technology and its focus on exosome-based delivery systems. The company has been working toward commercializing exosome products while simultaneously developing diagnostic applications, including its proprietary NANOG DNA cancer-screening technology.

In June, NexTel outlined a strategy designed to combine its biotechnology pipeline with revenue-generating healthcare operations. The company said its JumpstartRx and NueVistraMed operations were generating approximately $135,000–$140,000 in monthly revenue, while the broader platform included a network of more than 1,850 online and brick-and-mortar clinics.

That combination could be particularly interesting to investors because it creates the possibility of pairing longer-term biotechnology upside with operating healthcare assets.

Island 40 Acquisition Could Significantly Broaden the Platform

One of the most consequential developments arrived in July when NexTel amended its previously announced transaction to acquire Island 40 Group and its full subsidiary platform, rather than acquiring only individual healthcare businesses.

The proposed transaction carries total consideration of approximately $12.75 million, consisting of $3.5 million in cash and $9.25 million in preferred stock. Island 40's ecosystem includes JumpstartRx, NuevistraMed and additional platforms serving healthcare, wellness, institutional, sports, motorsports and consumer markets.

According to NexTel, Island 40 and its affiliated channels currently reach more than 300,000 patients per month.

For MAJI shareholders, the significance is the potential creation of a much larger distribution engine capable of helping NexTel introduce future products to consumers, healthcare providers, employers and institutional partners.

The transaction remains subject to customary closing conditions, financial review, documentation and due diligence, so investors should view the acquisition as a proposed strategic catalyst rather than a completed transaction.

Xycota: A Potentially Transformative Biotechnology Addition

Then came perhaps NexTel's most intriguing scientific development of the summer.

On August 5, the company announced a definitive Letter of Intent to acquire 100% of Xycota Biosciences, LLC, a preclinical biotechnology company developing exosome-delivered therapeutics designed to target damaged neural networks.

Xycota's lead program, XYCO-01, is being developed around the BDNF-TrkB neuroplasticity pathway, initially targeting Frontotemporal Dementia (FTD), with potential expansion into ALS, mild traumatic brain injury and other neurodegenerative diseases.

If completed, the acquisition could give NexTel exposure to a completely new therapeutic category while remaining closely aligned with its broader exosome strategy.

For investors, the important point is not that these programs are already commercial—it is that NexTel is attempting to build a multi-platform biotechnology company with multiple shots on goal.

Veterinary Oncology Opens Another Potential Market

NexTel $MAJI
has also begun looking beyond human healthcare.

In July, the company announced plans to roll out an early-stage cancer screening platform for companion animals using its diagnostic technology. The company intends to process blood samples centrally and work with veterinary oncologists to screen for multiple cancer profiles. NexTel cited a North American pet oncology opportunity exceeding $1 billion.

The veterinary initiative could ultimately provide another recurring diagnostic revenue opportunity while potentially expanding the addressable market for NexTel's technology.

The company's planned Maxasome PLUS formulation for household pets adds another dimension to this strategy. In August, NexTel said it anticipated introducing the veterinary formulation as its third commercial product later this year.

Scientific Validation Remains a Major Watch Point

NexTel's relationship with Pennsylvania State University is another important component of the story.

The company announced a first-of-its-kind exosome characterization study using advanced mass spectrometry to identify bioactive compounds within its proprietary mushroom-derived exosomes. The work is intended to help guide new intellectual property, formulations and product development.

Importantly, the company's latest SEC disclosure now states that the Penn State study is expected to be completed in Q1 2027, rather than the originally anticipated 2026 timeframe.

That delay is worth watching, but successful completion could become an important scientific and intellectual-property catalyst.

Baylor, International Partnerships and New Product Opportunities

NexTel also clarified in August that it and Xycota were finalizing a Material Transfer Agreement involving Baylor University for research examining the anti-aging properties of Maxasome PLUS. The company said product shipments for clinical testing were expected to follow execution of the agreement.

At the same time, NexTel disclosed that its equity ownership in a Japanese partnership had increased from 70% to 75%, with an additional 11.277 million LMMY shares expected to be issued to NexTel under the renegotiated arrangement.

These developments reinforce the increasingly international and diversified nature of the company's strategy.

The Next Major Catalyst: Commercialization

Perhaps the biggest near-term question for MAJI is whether NexTel can translate its technology and acquisitions into meaningful commercial activity.

The company previously announced that its initial exosome products had entered final stability testing after samples tested negative for several key contaminants. NexTel has targeted a Q4 2026 commercial launch and has discussed a potential OTCQB uplisting target for Q1 2027.

The September regulatory filings add another important piece to the picture. On September 3, the SEC qualified NexTel's amended Regulation A offering. The latest offering circular provides for up to 60 million company shares, with remaining company and selling-shareholder shares priced at $0.003 per share under the amended terms.

That financing structure provides potential capital for development, acquisitions, laboratory equipment, marketing and working capital—but investors should also carefully consider dilution and the company's stated risk factors.

What Investors Should Be Watching Now

The MAJI story heading into the final months of 2026 is increasingly defined by execution.

Key potential catalysts include:
  • Q4 2026 commercial launch of NexTel's exosome products.
  • Progress toward closing the Island 40 Group acquisition.
  • Development of the proposed Xycota Biosciences acquisition.
  • Baylor research and additional Maxasome PLUS testing.
  • Veterinary oncology and pet-product commercialization.
  • Advancement of the NANOG cancer-screening platform.
  • Completion of the Penn State exosome characterization study, now expected in Q1 2027.
  • Potential progress toward an OTCQB uplisting.

The Bigger Picture for MAJI

Rather than pursuing only one technology, NexTel is attempting to assemble an interconnected healthcare platform spanning exosome therapeutics, diagnostics, telehealth, pharmaceuticals, wellness, veterinary medicine and neuro-restoration.

If management can successfully execute on its commercialization plans, close its strategic acquisitions and generate meaningful recurring revenue while advancing its scientific pipeline, NexTel could look substantially different by the end of 2026 than it did at the beginning of the year.

For more information on MAJI visit: www.nextelmedical.com

Media Contact
Company Name: NexTel Medical Corp. (Stock Symbol: MAJI)
Contact Person: Matthew Dwyer, President and CEO
Email: [email protected]  or  [email protected]
Phone: +1 509-605-6533
Country: United States

DISCLAIMER: https://corporateads.com/disclaimer/

Disclosure listed on the CorporateAds website

Contact
CorporateAds
***@gmail.com

Photos: (Click photo to enlarge)




Source: CorporateAds

Read Full Story - Building a Diversified Healthcare Platform as Exosome Science, Telehealth, Diagnostics & Strategic Acquisitions Converge: NexTel Medical (OTCID: MAJI) | More news from this source

Press release distribution by PRLog
MORE NEWS
Fathers take on more, but mothers still bear heavier domestic workload
Oct 19, 2026
Fathers take on more, but mothers still bear heavier domestic workload

For a 33-year-old bank employee surnamed Jung raising a 3-year-old son in Seoul’s Yeongdeungpo District, coming home from work feels like starting a second shift. She uses a reduced working hours program for parents to leave work an hour or two early. Once her mother-in-law, who looks after the child while the couple are at work, heads home, Jung handles child care alone until her husband returns. “As soon as I get home, I feed my son dinner, bathe him and play with him. By then, my husband is home,” she said. “While he plays with our son, I finally get to shower, wash the dishes and tidy up. Then it’s time to put our son to bed.” Jung gets her first chance to sit down on the sofa after her son falls asleep, past 10 p.m. “Even though I leave work early, it feels like I work overtime every day,” she said. “My husband does quite a lot of child care, but our son tends to seek me out more, and I feel that a larger share of the housework naturally falls to me.” Government figures released Monday show that an uneven division of domestic duties persists among young working pa

Gov't, businesses team up to help retired detection dogs find new homes
Oct 19, 2026
Gov't, businesses team up to help retired detection dogs find new homes

The Ministry of Agriculture, Food and Rural Affairs last week joined Trinity Airways and Sono Pet Clubs & Resorts for a two-day pet adoption program, combining government support for retired detection dogs with private-sector assistance in event planning, accommodation and training. The Animal and Plant Quarantine Agency under the ministry provided guidance on adoption procedures and answered prospective owners’ questions. Trinity Airways, formerly T’way Air, organized the program, held Saturday and Sunday, while Sono Pet provided spaces for families and dogs to interact and rest, along with professional training support. Held at Sono Pet’s Vivaldi Park in Hongcheon, Gangwon Province, the program brought together three retired quarantine detection dogs and three prospective adoptive families selected through a screening process, according to the agency. The dogs were two English springer spaniels, aged 7 and 9, and a 9-year-old beagle. Activities included running together, treasure hunts and walks, giving participants opportunities to interact with the dogs. A trainer specializing

Finda to become 1st fintech firm to acquire savings bank
Oct 19, 2026
Finda to become 1st fintech firm to acquire savings bank

Finda, a loan comparison platform, is set to acquire a savings bank, in what would be a first for a Korean fintech company, as it looks to build an artificial intelligence (AI)-native bank, industry officials said Monday. The Financial Services Commission's subcommittee approved Finda's application to acquire Daewon Savings Bank on Friday. The regulator is set to make a final decision at its regular meeting Wednesday. Finda signed a deal in June to acquire all of Daewon Savings Bank's shares for about 12 billion won ($9 million). The acquisition would allow the company to move beyond matching borrowers with lenders and offer financial services directly, including loans and deposits. Once the deal receives final approval, Finda plans to appoint a new CEO through board and shareholder meetings. The fintech firm aims to turn the lender into an AI-native bank, relying on digital services rather than a traditional network of branches. It plans to draw on AI technology and loan-comparison data it has collected since 2019 to expand its online lending business nationwide, the firm said. The compa

Hyundai Rotem to acquire Hyundai Wia's defense unit for $252 mil.
Oct 19, 2026
Hyundai Rotem to acquire Hyundai Wia's defense unit for $252 mil.

Hyundai Rotem, a defense affiliate of Hyundai Motor Group, said Monday it will acquire Hyundai Wia's defense business for 358.4 billion won ($252 million) to strengthen its weapons production capabilities. Hyundai Rotem said in a regulatory filing that it plans to acquire Hyundai Wia's defense business, which manufactures key components for Korea's K9 self-propelled howitzers and K2 main battle tanks. The acquisition is expected to boost Hyundai Rotem's competitiveness in the global market by bringing more of its weapons production capabilities in-house, particularly for its flagship K2 tanks. In August 2025, the company signed a $6.5 billion follow-up contract to supply K2 tanks to Poland. Five months later, it reached a comprehensive agreement with Peru to supply 195 ground weapons systems, including 54 K2 tanks. For Hyundai Wia, the sale is part of broader restructuring efforts to shift its focus toward future mobility technologies, including vehicle electrification and software-defined vehicles (SDVs). The company plans to use the proceeds from the sale to invest in new growth areas,

Global AI & Digital Summit kicks off 3-day run in Seoul
Oct 19, 2026
Global AI & Digital Summit kicks off 3-day run in Seoul

A global event aimed at exploring how artificial intelligence (AI) and digital transformation can deliver practical development gains kicked off its three-day run in Seoul on Monday, the science ministry said. The Global AI & Digital Summit, co-hosted by the ministry and the World Bank Group — a family of five institutions that makes leveraged loans to developing countries —brought together government officials from some 60 nations, as well as development partners, private sector leaders and researchers. This year marks the first time the summit was held outside of the United States, the ministry added. The event will begin with an AI and Digital Ministerial meeting, co-chaired by Science Minister Bae Kyung-hoon and Kim Sang-bu, the vice president for digital and AI at the World Bank Group, followed by policy forums and exhibitions from participating companies. Korea has been hosting the AI and digital ministerial meeting since 2005, with the most recent gathering held last year on the sidelines of the Asia Pacific Economic Co-operation (APEC) forum. Second Vice Science Minister Ryu J

Points beat percentages: Why three in four Singaporeans think their spare cash is underperforming
Oct 19, 2026
Points beat percentages: Why three in four Singaporeans think their spare cash is underperforming

A Singaporean who will argue over a 50-cent difference in cashback at a hawker centre may have no idea what their savings account pays. New research suggests that person is the norm. Some 89 per cent of Singapore residents hold spare cash, according to a survey of 1,000 people conducted by research firm Milieu. Among […] The post Points beat percentages: Why three in four Singaporeans think their spare cash is underperforming appeared first on e27.

Singapore employers say they offer burnout support. Half their staff say they’ve never seen it
Oct 19, 2026
Singapore employers say they offer burnout support. Half their staff say they’ve never seen it

Many Singapore companies offer a peculiar kind of workplace benefit: one that exists mostly in the HR handbook. Managers will tell you it is there. Employees, asked the same question, will tell you they have never come across it. That gap sits at the centre of the Jobstreet by SEEK Singapore Workplace Culture Study 2026. […] The post Singapore employers say they offer burnout support. Half their staff say they’ve never seen it appeared first on e27.

Will the upcoming Federal Reserve meeting crush the bullish push toward the US$84,000 target?
Oct 19, 2026
Will the upcoming Federal Reserve meeting crush the bullish push toward the US$84,000 target?

Global financial ecosystems present a fascinating landscape today, as virtual currencies are in a modest recovery phase. Bitcoin leads this upward trajectory, up 0.94 per cent over the past 24 hours. The premier cryptocurrency trades at exactly US$82,204.31. This price action slightly outperforms a broadly flat digital asset sector. The total cryptocurrency capitalisation registers a […] The post Will the upcoming Federal Reserve meeting crush the bullish push toward the US$84,000 target? appeared first on e27.

Beyond play-to-earn: 14 Southeast Asian gaming and sports-tech startups still in the game
Oct 19, 2026
Beyond play-to-earn: 14 Southeast Asian gaming and sports-tech startups still in the game

Southeast Asia has spent the last decade trying to turn its obsession with play into businesses. Some bets worked spectacularly, some blew up just as spectacularly, and a surprising number of the best ones never raised much venture money at all. The Web3 gaming boom of 2021 is the cautionary tale everyone remembers: blockchain games, […] The post Beyond play-to-earn: 14 Southeast Asian gaming and sports-tech startups still in the game appeared first on e27.

Gen Z is bringing its own AI to work. Singapore’s SMEs need rules, not bans
Oct 19, 2026
Gen Z is bringing its own AI to work. Singapore’s SMEs need rules, not bans

Young workers in Singapore are not waiting for their employers to roll out AI. They are already using it, often on personal devices and often without anyone watching. According to “What Gen Z Workers Want 2026”, a study commissioned by Deel and conducted with YouGov and ThinkerTank, 49 per cent of Singapore workers aged 18 […] The post Gen Z is bringing its own AI to work. Singapore’s SMEs need rules, not bans appeared first on e27.

When AI takes your side in a workplace conflict
Oct 19, 2026
When AI takes your side in a workplace conflict

Workplace conflict rarely arrives as a clean set of facts. By the time we decide that a manager is undermining us, a colleague is being deliberately difficult, or someone on the team cannot be trusted, we have usually spent some time interpreting what happened. We have noticed particular behaviours, connected them with earlier experiences, filled […] The post When AI takes your side in a workplace conflict appeared first on e27.

Faster, smarter, but more fragile? Rethinking communications resilience in Southeast Asia
Oct 19, 2026
Faster, smarter, but more fragile? Rethinking communications resilience in Southeast Asia

Southeast Asia has spent the past decade moving rapidly towards a more connected future. Fibre networks have replaced much of the region’s older copper infrastructure, smartphones have become the primary gateway to services, and communications, payments, government functions and commerce have increasingly shifted online. That transition has brought enormous benefits, but it has also created […] The post Faster, smarter, but more fragile? Rethinking communications resilience in Southeast Asia appeared first on e27.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

About Us

Always dynamic, always updated, The Witness Daily ensures minute-by-minute update to the most pressing issues, curated specifically to cater to critical newsreaders of our time.

Copyright © 2015 - 2026 Redshift Daily. All Rights Reserved.